Publication

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Chat with Graph Search

Delivery of A Chemically Modified Noncoding RNA Domain Improves Dystrophic Myotube Function

A CTCF-dependent mechanism underlies the Hox timer relation to a segmented body plan

A Spectral Ansatz for The Long-Time Homogenization of The Wave Equation

Understanding and Enhancing Digital Wellbeing Dimensions: Empirical Studies on Smartphone Usage Patterns and Recommendations of Micro-Informative Content

Variational quantum time evolution without the quantum geometric tensor

Soft Robotics: A Route to Equality, Diversity, and Inclusivity in Robotics

Re-design of EU DEMO with a low aspect ratio

A state-of-the-art, systematic review of indoor environmental quality studies in work-from-home settings

Comparative Evaluation of Lipofectamine and Dendrimer for Transfection of Short RNA Into Human T47D and MCF-10A Cell Lines

Single-cell biology: what does the future hold?

Appropriations and Uses of Travel Time

The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma

Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesis

Tri-axial H-Field Sensor with Frequency-shaped Response in the band 400 MHz - 6 GHz

Exploiting Marginal Stability in Slow-Fast Quasilinear Dynamical Systems

Fully co-factor-free ClearTau platform produces seeding-competent Tau fibrils for reconstructing pathological Tau aggregates

Between digital and territorial turns: A forking path

A review of cybersickness in head‐mounted displays: raising attention to individual susceptibility

Analytic Approximation of In-Body Path Loss for Implanted Antennas

NORM TORI OF ETALE ALGEBRAS AND UNRAMIFIED BRAUER GROUPS